Transforming growth factor beta and cyclosporin A inhibit the inducible activity of the interleukin-2 gene in T cells through a noncanonical octamer-binding site

Mol Cell Biol. 1993 Feb;13(2):1155-62. doi: 10.1128/mcb.13.2.1155-1162.1993.

Abstract

Transforming growth factor beta (TGF-beta) has a growth-inhibitory effect on numerous different cell types of the immune system, including T lymphocytes. We show in this study that the inhibitory action of TGF-beta on T lymphocytes is accompanied by a block of interleukin 2 (IL-2) gene expression which is mediated, at least in part, by inhibition of IL-2 promoter/enhancer activity. The functional analysis of cis-regulatory (proto-enhancer) elements of the IL-2 enhancer/promoter region showed that the most TGF-beta-responsive element maps to its so-called upstream promoter site. The proto-enhancer activity of the upstream promoter site element is also inhibited by cyclosporin A. The upstream promoter site DNA harbors two noncanonical, closely linked binding sequences for octamer and AP-1-like factors. Both sites are involved in the establishment of IL-2 enhancer activity. Since the activity of genuine octamer sites but not that of AP-1-binding sites is also impaired by TGF-beta and cyclosporin A in El4 T lymphoma cells, we conclude that both immunosuppressives interfere with the activity but not the DNA binding of octamer factors in T lymphocytes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Base Sequence
  • Binding Sites
  • Cyclosporine / pharmacology*
  • DNA
  • Enhancer Elements, Genetic
  • Gene Expression Regulation / drug effects*
  • Humans
  • Interleukin-2 / genetics*
  • Interleukin-2 / metabolism
  • Mice
  • Molecular Sequence Data
  • Promoter Regions, Genetic
  • T-Lymphocytes / drug effects*
  • T-Lymphocytes / metabolism
  • Transforming Growth Factor beta / pharmacology*
  • Tumor Cells, Cultured

Substances

  • Interleukin-2
  • Transforming Growth Factor beta
  • Cyclosporine
  • DNA